BioMarin Pharmaceuticals
BMRN
BMRN
581 hedge funds and large institutions have $12.9B invested in BioMarin Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 243 increasing their positions, 174 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $12B → $12.9B (+$821M)
0.08% less ownership
Funds ownership: 96.13% → 96.05% (-0.08%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
581
Holding in Top 10
6
Calls
$97.7M
Puts
$87.7M
Top Buyers
| 1 | +$110M | |
| 2 | +$108M | |
| 3 | +$81.2M | |
| 4 |
Goldman Sachs
New York
|
+$72.9M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$56.3M |
Top Sellers
| 1 | -$258M | |
| 2 | -$96.1M | |
| 3 | -$68.7M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$56.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$44.8M |